218 related articles for article (PubMed ID: 32391733)
1. Treprostinil in the treatment of pulmonary arterial hypertension.
Feldman J; Habib N; Fann J; Radosevich JJ
Future Cardiol; 2020 Nov; 16(6):547-558. PubMed ID: 32391733
[TBL] [Abstract][Full Text] [Related]
2. The potential for inhaled treprostinil in the treatment of pulmonary arterial hypertension.
Gessler T; Seeger W; Schmehl T
Ther Adv Respir Dis; 2011 Jun; 5(3):195-206. PubMed ID: 21300738
[TBL] [Abstract][Full Text] [Related]
3. Transition protocol from subcutaneous treprostinil to intravenous epoprostenol in deteriorating patients with pulmonary arterial hypertension.
Mouratoglou SA; Patsiala A; Feloukidis C; Karvounis H; Giannakoulas G
Int J Cardiol; 2020 May; 306():187-189. PubMed ID: 32115272
[TBL] [Abstract][Full Text] [Related]
4. Treprostinil for the treatment of pulmonary arterial hypertension.
Torres F; Rubin LJ
Expert Rev Cardiovasc Ther; 2013 Jan; 11(1):13-25. PubMed ID: 23259441
[TBL] [Abstract][Full Text] [Related]
5. Overview of treprostinil sodium for the treatment of pulmonary arterial hypertension.
Budev MM; Minai OA; Arroliga AC
Drugs Today (Barc); 2004 Mar; 40(3):225-34. PubMed ID: 15148531
[TBL] [Abstract][Full Text] [Related]
6. Oral treprostinil for the treatment of pulmonary arterial hypertension.
de Lartigue J
Drugs Today (Barc); 2014 Aug; 50(8):557-65. PubMed ID: 25187906
[TBL] [Abstract][Full Text] [Related]
7. Treprostinil Administered to Treat Pulmonary Arterial Hypertension Using a Fully Implantable Programmable Intravascular Delivery System: Results of the DelIVery for PAH Trial.
Bourge RC; Waxman AB; Gomberg-Maitland M; Shapiro SM; Tarver JH; Zwicke DL; Feldman JP; Chakinala MM; Frantz RP; Torres F; Cerkvenik J; Morris M; Thalin M; Peterson L; Rubin LJ
Chest; 2016 Jul; 150(1):27-34. PubMed ID: 27396777
[TBL] [Abstract][Full Text] [Related]
8. Different efficacy of inhaled and oral medications in pulmonary hypertension.
AbuHalimeh BJ; Parambil JG; Tonelli AR
Heart Lung; 2017; 46(4):334-337. PubMed ID: 28527831
[TBL] [Abstract][Full Text] [Related]
9. Inhaled treprostinil for the treatment of pulmonary arterial hypertension.
LeVarge BL; Channick RN
Expert Rev Respir Med; 2012 Jun; 6(3):255-65. PubMed ID: 22788940
[TBL] [Abstract][Full Text] [Related]
10. Transition from intravenous or subcutaneous prostacyclin therapy to inhaled treprostinil in patients with pulmonary arterial hypertension: a retrospective case series.
Enderby CY; Soukup M; Al Omari M; Zeiger T; Burger C
J Clin Pharm Ther; 2014 Oct; 39(5):496-500. PubMed ID: 24806480
[TBL] [Abstract][Full Text] [Related]
11. Treprostinil for pulmonary hypertension.
Skoro-Sajer N; Lang I; Naeije R
Vasc Health Risk Manag; 2008; 4(3):507-13. PubMed ID: 18827901
[TBL] [Abstract][Full Text] [Related]
12. A Comprehensive Review of Treprostinil Pharmacokinetics via Four Routes of Administration.
Kumar P; Thudium E; Laliberte K; Zaccardelli D; Nelsen A
Clin Pharmacokinet; 2016 Dec; 55(12):1495-1505. PubMed ID: 27286723
[TBL] [Abstract][Full Text] [Related]
13. Assessment of Inhaled Treprostinil Palmitil, Inhaled and Intravenous Treprostinil, and Oral Selexipag in a Sugen/Hypoxia Rat Model of Pulmonary Arterial Hypertension.
Corboz MR; Plaunt AJ; Malinin VS; Li Z; Gauani H; Chun D; Cipolla D; Perkins WR; Chapman RW
J Pharmacol Exp Ther; 2022 Oct; 383(1):103-116. PubMed ID: 36507843
[TBL] [Abstract][Full Text] [Related]
14. Experiences with treprostinil in the treatment of pulmonary arterial hypertension.
Stream AR; Bull TM
Ther Adv Respir Dis; 2012 Oct; 6(5):269-76. PubMed ID: 22868690
[TBL] [Abstract][Full Text] [Related]
15. Oral treprostinil diethanolamine for pulmonary arterial hypertension.
Feldman J; Im Y; Gill K
Expert Rev Clin Pharmacol; 2015 Jan; 8(1):55-60. PubMed ID: 25409915
[TBL] [Abstract][Full Text] [Related]
16. Inhaled treprostinil sodium for the treatment of pulmonary arterial hypertension.
Ferrantino M; White RJ
Expert Opin Pharmacother; 2011 Nov; 12(16):2583-93. PubMed ID: 21988216
[TBL] [Abstract][Full Text] [Related]
17. Transition from IV epoprostenol to oral treprostinil in a patient with group 1 pulmonary arterial hypertension.
Sarangarm P; Elwood K
Am J Health Syst Pharm; 2021 Nov; 78(23):2110-2115. PubMed ID: 34100906
[TBL] [Abstract][Full Text] [Related]
18. Optimal use of treprostinil in pulmonary arterial hypertension: a guide to the correct use of different formulations.
Skoro-Sajer N
Drugs; 2012 Dec; 72(18):2351-63. PubMed ID: 23231023
[TBL] [Abstract][Full Text] [Related]
19. Inhaled treprostinil for the treatment of pulmonary arterial hypertension.
Poms A; Kingman M
Crit Care Nurse; 2011 Dec; 31(6):e1-10. PubMed ID: 22135338
[TBL] [Abstract][Full Text] [Related]
20. Intravenous treprostinil as an add-on therapy in patients with pulmonary arterial hypertension.
Olsson KM; Richter MJ; Kamp JC; Gall H; Heine A; Ghofrani HA; Fuge J; Ewert R; Hoeper MM
J Heart Lung Transplant; 2019 Jul; 38(7):748-756. PubMed ID: 31128966
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
